University of California San Francisco

Bilal Hameed, MBBS

Bilal Hameed - 144
Bilal
Hameed
MBBS

Professor of Medicine
Hepatology and Liver Transplantation
Department of Medicine

Address

400 Parnassus Avenue, #A744
San Francisco, CA 94143
United States

Email: [email protected]
Phone: 415-353-2318

ORCID: 0000-0003-2200-8428

Biography

I am a Professor of Medicine and Ambulatory Director of Hepatology. I was the program director for transplant hepatology fellowship. Beside busy clinically my research interest includes nonalcoholic steatohepatitis, PSC, ALF, HCC and cirrhosis. I am the co-PI for NIH funded Liver Cirrhosis Network (LCN) and site-PI for NIH funded NASH-CRN. I am the PI for many clinical trials in NASH and PSC.

Videos

Education

Institution Degree Dept or School End Date
University of California, San Francisco Transplant Hepatology fellowship 07/2010
University of Minnesota Gastroenterology fellowship 07/2009
University of Minnesota Internal Medicine Residency 07/2006
Dow M.D. School of Medicine 2000

Board Certifications

American Board of Internal Medicine
American Board of Internal Medicine - Gastroenterology

Clinical Expertise

Alcoholic Liver Disease
Autoimmune Hepatitis
Benign Liver Tumors
Cirrhosis
Fulminant Hepatic Failure
Hepatitis B
Hepatitis C
Hepatocellular Carcinoma (Liver Cancer)
Living Donor Liver Transplantation
Liver Transplantation
Nonalcoholic Fatty Liver Disease
Primary Biliary Cirrhosis
Primary Sclerosing Cholangitis

Clinical Trials

  1. Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis (NCT03587831)
    Related Conditions: Nonalcoholic Steatohepatitis, Steatohepatitis, Liver Disease, Nonalcoholic Fatty Liver Disease| Start Date: | End Date:

Program Affiliations

UCSF Liver Transplantation Program

Research Interests

Epidemiology and management of NAFLD
Sleep apnea in NAFLD
Modeling outcomes in advanced liver disease and liver transplantation.

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 49
  1. Optimizing liver transplant candidacy in patients with cirrhosis and obesity.
    Ha NB, Heimbach JK, Hameed B| | PubMed
  2. Granulomatous hepatitis, a mystery solved.
    Bahceci D, Hameed B, Gill RM| | PubMed
  3. Recipients of Early Liver Transplants for Alcohol-Related Liver Disease May Reside in Areas With Lower Social Vulnerability.
    Flanary J, King EA, Baimaji F, Strauss AT, Welch N, Bellar A, Sherman CB, Hameed B, Khalili M, Dasarathy S, Cameron AM, Chen PH| | PubMed
  4. The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints.
    Tapper EB, Goldberg D, Parikh ND, Terrault NA, Welch N, Sharpton S, Hameed B, Khalili M, Stolz A, Verna EC, Brown RS, Sanyal AJ, VanWagner L, Ladner DP, Moylan CA, Diehl AM, Jones PD, Loomba R, Dasarathy S, Simonetto DA, Shah VH, Bajaj JS, LCN Study Group| | PubMed
  5. Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD.
    Gawrieh S, Vilar-Gomez E, Wilson LA, Pike F, Kleiner DE, Neuschwander-Tetri BA, Diehl AM, Dasarathy S, Kowdley KV, Hameed B, Tonascia J, Loomba R, Sanyal AJ, Chalasani N, NASH Clinical Research Network| | PubMed
  6. African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis.
    Yazdanfar M, Zepeda J, Dean R, Wu J, Levy C, Goldberg D, Lammert C, Prenner S, Reddy KR, Pratt D, Forman L, Assis DN, Lytvyak E, Montano-Loza AJ, Gordon SC, Carey EJ, Ahn J, Schlansky B, Korzenik J, Karagozian R, Hameed B, Chandna S, Yu L, Bowlus CL| | PubMed
  7. Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease.
    Sanyal AJ, Williams SA, Lavine JE, Neuschwander-Tetri BA, Alexander L, Ostroff R, Biegel H, Kowdley KV, Chalasani N, Dasarathy S, Diehl AM, Loomba R, Hameed B, Behling C, Kleiner DE, Karpen SJ, Williams J, Jia Y, Yates KP, Tonascia J| | PubMed
  8. Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC.
    Trauner M, Bowlus CL, Gulamhusein A, Hameed B, Caldwell SH, Shiffman ML, Landis C, Muir AJ, Billin A, Xu J, Liu X, Lu X, Chung C, Myers RP, Kowdley KV| | PubMed
  9. Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry.
    Rao A, Rule JA, Hameed B, Ganger D, Fontana RJ, Lee WM| | PubMed
  10. Machine learning to predict waitlist dropout among liver transplant candidates with hepatocellular carcinoma.
    Kwong A, Hameed B, Syed S, Ho R, Mard H, Arshad S, Ho I, Suleman T, Yao F, Mehta N| | PubMed
  11. Impact of the Corona Virus Disease 2019 Pandemic on Hepatology Practice and Provider Burnout.
    Russo MW, Kwok R, Serper M, Ufere N, Hameed B, Chu J, Goacher E, Lingerfelt J, Terrault N, Reddy KR| | PubMed
  12. ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis.
    Mazzini GS, Augustin T, Noria S, Romero-Marrero C, Li N, Hameed B, Eisenberg D, Azagury DE, Ikramuddin S| | PubMed
  13. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
    Sanyal AJ, Van Natta ML, Clark J, Neuschwander-Tetri BA, Diehl A, Dasarathy S, Loomba R, Chalasani N, Kowdley K, Hameed B, Wilson LA, Yates KP, Belt P, Lazo M, Kleiner DE, Behling C, Tonascia J, NASH Clinical Research Network (CRN)| | PubMed
  14. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease.
    Fix OK, Blumberg EA, Chang KM, Chu J, Chung RT, Goacher EK, Hameed B, Kaul DR, Kulik LM, Kwok RM, McGuire BM, Mulligan DC, Price JC, Reau NS, Reddy KR, Reynolds A, Rosen HR, Russo MW, Schilsky ML, Verna EC, Ward JW, Fontana RJ, AASLD COVID-19 Vaccine Working Group| | PubMed
  15. Prognostic Value of the 13 C-Methacetin Breath Test in Adults with Acute Liver Failure and Non-acetaminophen Acute Liver Injury.
    Fontana RJ, Stravitz RT, Durkalski V, Hanje J, Hameed B, Koch D, Reuben A, Ganger D, Olson J, Liou I, McGuire BM, Clasen K, Lee WM| | PubMed
  16. Psychological Health of Surgeons in a Time of COVID-19: A Global Survey.
    Tan YQ, Wang Z, Yap QV, Chan YH, Ho RC, Hamid ARAH, Landaluce-Olavarria A, Pellino G, Gauhar V, Chand M, Wroclawski ML, Hameed BZ, Ling SK, Sengupta S, Gallo G, Chiu PK, Tanidir Y, Tallada MPV, Garcia BN, Colleoni R, Abiddin ZAZ, Campi R, Esperto F, Carrion D, Elterman D, Chung ASJ, Ng ACF, Moschini M, Rivas JG, Mayol J, Teoh JY, Chiong E, SoMe4Surgery working group Collaborators| | PubMed
  17. Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic.
    Mehta N, Parikh ND, Kelley RK, Hameed B, Singal AG| | PubMed
  18. Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.
    Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, Pratt DS, Russo MW, Schilsky ML, Verna EC, Loomba R, Cohen DE, Bezerra JA, Reddy KR, Chung RT| | PubMed
  19. The Association Between Nonalcoholic Fatty Liver Disease and Risk of Cardiovascular Disease, Stroke, and Extrahepatic Cancers.
    Veracruz N, Hameed B, Saab S, Wong RJ| | PubMed
  20. Clinicopathological features and outcomes of parenchymal rejection in liver transplant biopsies.
    Fels Elliott DR, Tavakol M, Lucas CH, Sheahon K, Kakar S, Hameed B, Ferrell LD, Gill RM| | PubMed
  21. Nonalcoholic Steatohepatitis: A Review.
    Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S| | PubMed
  22. Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels.
    Gawrieh S, Wilson LA, Cummings OW, Clark JM, Loomba R, Hameed B, Abdelmalek MF, Dasarathy S, Neuschwander-Tetri BA, Kowdley K, Kleiner D, Doo E, Tonascia J, Sanyal A, Chalasani N, NASH Clinical Research Network| | PubMed
  23. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014.
    Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A| | PubMed
  24. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
    Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV| | PubMed
  25. Acetaminophen is Undetectable in Plasma From More Than Half of Patients Believed to Have Acute Liver Failure Due to Overdose.
    Leventhal TM, Gottfried M, Olson JC, Subramanian RM, Hameed B, Lee WM, Acute Liver Failure Study Group| | PubMed
  26. Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States.
    Kim D, Yoo ER, Li AA, Fernandes CT, Tighe SP, Cholankeril G, Hameed B, Ahmed A| | PubMed
  27. History of Marijuana Use Does Not Affect Outcomes on the Liver Transplant Waitlist.
    Kotwani P, Saxena V, Dodge JL, Roberts J, Yao F, Hameed B| | PubMed
  28. Hilar cholangiocarcinoma associated with immunoglobulin G4-positive plasma cells and elevated serum immunoglobulin G4 levels.
    Azeem N, Ajmera V, Hameed B, Mehta N| | PubMed
  29. Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia.
    Stravitz RT, Gottfried M, Durkalski V, Fontana RJ, Hanje AJ, Koch D, Hameed B, Ganger D, Subramanian RM, Bukofzer S, Ravis WR, Clasen K, Sherker A, Little L, Lee WM, Acute Liver Failure Study Group| | PubMed
  30. Clinical and metabolic effects associated with weight changes and obeticholic acid in non-alcoholic steatohepatitis.
    Hameed B, Terrault NA, Gill RM, Loomba R, Chalasani N, Hoofnagle JH, Van Natta ML, NASH CRN| | PubMed
  31. Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women.
    Rubin JB, Hameed B, Gottfried M, Lee WM, Sarkar M, Acute Liver Failure Study Group| | PubMed
  32. Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study.
    Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, Durkalski V, Larson AM, Liou I, Fix O, Schilsky M, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Smith A, Brown R, Crippin J, Harrison ME, Koch D, Munoz S, Reddy KR, Rossaro L, Satyanarayana R, Hassanein T, Hanje AJ, Olson J, Subramanian R, Karvellas C, Hameed B, Sherker AH, Robuck P, Lee WM| | PubMed
  33. Acute liver injury and acute liver failure from mushroom poisoning in North America.
    Karvellas CJ, Tillman H, Leung AA, Lee WM, Schilsky ML, Hameed B, Stravitz RT, McGuire BM, Fix OK, United States Acute Liver Failure Study Group| | PubMed
  34. Emerging Therapies for Nonalcoholic Fatty Liver Disease.
    Hameed B, Terrault N| | PubMed
  35. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
    Kelley RK, Magbanua MJ, Butler TM, Collisson EA, Hwang J, Sidiropoulos N, Evason K, McWhirter RM, Hameed B, Wayne EM, Yao FY, Venook AP, Park JW| | PubMed
  36. Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria.
    Yao FY, Mehta N, Flemming J, Dodge J, Hameed B, Fix O, Hirose R, Fidelman N, Kerlan RK, Roberts JP| | PubMed
  37. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.
    Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, Chalasani N, Dasarathy S, Diehl AM, Hameed B, Kowdley KV, McCullough A, Terrault N, Clark JM, Tonascia J, Brunt EM, Kleiner DE, Doo E, NASH Clinical Research Network| | PubMed
  38. Response to letter to the editors.
    Yao FY, Hameed B, Mehta N, Roberts JP| | PubMed
  39. Combined effects of recipient age and model for end-stage liver disease score on liver transplantation outcomes.
    Sharpton SR, Feng S, Hameed B, Yao F, Lai JC| | PubMed
  40. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
    Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY| | PubMed
  41. Adult-Onset Fatal Neurohepatopathy in a Woman Caused by MPV17 Mutation.
    Mendelsohn BA, Mehta N, Hameed B, Pekmezci M, Packman S, Ralph J| | PubMed
  42. Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.
    Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A, Merriman R, Hameed B, Doo E, Kleiner DE, Behling C, Loomba R, NASH CRN| | PubMed
  43. Clinical predictors of EMG-confirmed cervical and lumbosacral radiculopathy.
    Hassan A, Hameed B, Islam M, Khealani B, Khan M, Shafqat S| | PubMed
  44. Pretransplant severe hepatic encephalopathy, peritransplant sodium and post-liver transplantation morbidity and mortality.
    Brandman D, Biggins SW, Hameed B, Roberts JP, Terrault NA| | PubMed
  45. Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review.
    Vagefi PA, Klein I, Gelb B, Hameed B, Moff SL, Simko JP, Fix OK, Eilers H, Feiner JR, Ascher NL, Freise CE, Bass NM| | PubMed
  46. Risk of multiple sclerosis after idiopathic optic neuritis in a Pakistani population.
    Kazim SF, Islam M, Khan M, Hameed B, Shafqat S| | PubMed
  47. Using higher risk organs for liver transplantation: in whom and at what price?
    Hameed B, Lake JR| | PubMed
  48. Stroke in Pakistan.
    Khealani BA, Hameed B, Mapari UU| | PubMed
  49. Prognostic indicators in patients with primary intraventricular haemorrhage.
    Hameed B, Khealani BA, Mozzafar T, Wasay M| | PubMed